HealthEquity Inc (HQY)

In late March 2025, HealthEquity's stock declined by 17% due to increasing cyber threats and fraudulent activities, leading to a securities class action investigation. In August 2025, RBC Capital lowered its price target on HealthEquity to $109.00 from $117.00. HealthEquity reported $0.92 earnings per share in its quarterly earnings results on September 2nd, 2025, meeting consensus estimates, with revenue exceeding estimates at $325.80 million. Insider transactions include EVP Delano Ladd selling 6,000 shares in September 2025 and EVP Michael Henry Fiore selling 1,781 shares in October 2025. Analysts have a "Moderate Buy" consensus rating for HealthEquity, with a price target of $121.31.

HealthEquity has demonstrated strong financial performance and consistent growth, with a 14% increase in HSAs and a 9% increase in total accounts as of January 31, 2025. HSA assets grew by 27%, and total revenue grew by 8.6% year-over-year in Q2/26, indicating steady demand for its services rather than pronounced seasonality.

HealthEquity, Inc. (HQY) is a financial technology and business services company founded in 2002 and headquartered in Draper, Utah, operating in the Managed Health Care industry. It manages health savings accounts (HSAs) and other consumer-directed benefits (CDBs), totaling 14.5 million accounts as of July 31, 2022, with $20.5 billion in HSA assets. The company offers an investment platform, automated investment advisory services, and administers pre-tax commuter benefit programs.

HealthEquity, Inc.'s headquarters are located in Draper, Utah, United States. Its operations and subsidiaries are primarily based in the United States. HealthEquity is listed on NasdaqGS in the US and is traded on international exchanges including Deutsche Boerse AG, Bolsa Mexicana de Valores, Borsa Italiana, and Berne Stock Exchange.

HealthEquity's brand reputation was significantly impacted in March 2024 due to a data breach that exposed the personal information of over 4 million patients. This event contributed to a stock decline in March 2025 and triggered a securities class action investigation.

Institutional investors, including Farther Finance Advisors LLC and Cullen Frost Bankers Inc., have significantly increased their holdings in HealthEquity, resulting in them owning 99.55% of the company's stock. Corporate insiders own 1.50% of HealthEquity's stock.